Why Is Midazolam So Hard to Find? [Explained for 2026]

If you or someone you care for depends on midazolam — whether as an injectable sedative, an oral syrup, or the nasal spray Nayzilam — you may have run into frustrating availability gaps at your local pharmacy. Midazolam is a critical medication used in procedural sedation, ICU care, and emergency seizure management. Yet despite its importance, it doesn't always sit neatly on pharmacy shelves. In 2026, understanding why this happens can help you plan ahead and avoid dangerous gaps in care.

What Is Midazolam and Who Uses It?

Midazolam is a short-acting benzodiazepine that has been FDA-approved since 1985. It is widely used for procedural sedation before surgeries and diagnostic procedures, anesthesia induction, continuous sedation of ICU patients on ventilators, and as a rescue therapy for seizure clusters. The original brand Versed has been discontinued, but generic injectable forms remain widely manufactured and used in hospitals. Nayzilam, a midazolam nasal spray, is still available as a branded product for at-home seizure rescue.

Unlike oral pills taken daily at home, most midazolam formulations are administered in clinical settings — operating rooms, emergency departments, dental offices, and ICUs. This means the patients and caregivers most likely to search for it at retail pharmacies are those prescribed Nayzilam nasal spray for epilepsy or the oral syrup for pediatric procedural sedation — two situations where outpatient supply really matters.

Why Is Midazolam Hard to Find at Pharmacies?

Several overlapping factors can make midazolam difficult to locate, even when there is no formal FDA-declared shortage:

Sterile injectable manufacturing complexity. Midazolam injection is a sterile injectable drug. These are among the most difficult and expensive drugs to manufacture, with limited production facilities in the U.S. A single quality issue at one plant can remove a major share of national supply overnight.

Demand spikes from shortage surges. When related medications run short — as happened during the IV lorazepam (Ativan) shortage in 2022-2023 — hospitals and clinics pivoted to midazolam, causing unexpected demand spikes that strained supply chains.

Retail pharmacy stocking patterns. Because most midazolam is used in hospitals and surgery centers, many retail pharmacies simply don't stock it regularly. Nayzilam (midazolam nasal spray) is a specialty product that not every chain pharmacy carries.

Schedule IV controlled substance status. Midazolam is a DEA Schedule IV controlled substance, which means pharmacies must follow additional record-keeping and dispensing rules. Some pharmacies limit their controlled substance inventory, which can make specific formulations harder to source.

Formulation fragmentation. Midazolam comes in many different forms: 1 mg/mL and 5 mg/mL injectable vials, premixed IV bags in 0.9% NaCl, 2 mg/mL oral syrup, and Nayzilam nasal spray. Each formulation is stocked differently, so even if one version is available, the specific form your prescription requires may not be.

Has Midazolam Been in Shortage Before?

Yes. Midazolam injectable has appeared on the FDA drug shortage database at multiple points over the years. During the COVID-19 pandemic, demand for ICU sedatives — including midazolam — surged as hospitals cared for critically ill patients on ventilators, straining supplies of multiple benzodiazepines. In 2022 and 2023, a shortage of IV lorazepam led many clinicians to substitute midazolam, placing further pressure on its supply. As of early 2026, midazolam is not listed on the FDA's active shortage database, but localized supply gaps at specific pharmacies and distributors do occur.

Who Is Most Likely to Have Trouble Finding Midazolam?

Supply challenges are most noticeable for people in these situations:

Epilepsy patients prescribed Nayzilam nasal spray for at-home seizure rescue — especially if their pharmacy doesn't routinely stock specialty benzodiazepines

Parents of children needing the 2 mg/mL oral syrup for pediatric procedural sedation

Patients requiring a specific vial concentration (1 mg/mL vs. 5 mg/mL) that their local pharmacy doesn't carry

Outpatient dental or procedural settings that need to pre-procure midazolam from a retail or specialty pharmacy

What Should You Do If You Can't Find Midazolam?

First, don't panic — and don't skip doses or delay needed procedures. Instead, take these steps:

Call multiple pharmacies. Availability varies widely between pharmacies, even in the same zip code. Independent pharmacies sometimes have stock that chains do not.

Ask your prescriber about formulation flexibility. If one concentration is unavailable, your provider may be able to adjust the dose or prescribe an equivalent formulation.

Consider specialty pharmacies. For Nayzilam, specialty pharmacies that focus on neurology medications may be better stocked than general retail pharmacies.

Use medfinder. medfinder.com calls pharmacies near you to find out which ones can actually fill your midazolam prescription — saving you hours of phone calls.

Are There Alternatives to Midazolam?

In some situations, your provider may consider alternatives. For seizure rescue, Valtoco (diazepam nasal spray) is an FDA-approved alternative for patients 2 years and older. For procedural sedation, lorazepam or propofol may be substituted in clinical settings. Always discuss any potential alternatives with your doctor or specialist — never switch benzodiazepines on your own.

For a deeper look at specific alternatives, see our guide: Alternatives to Midazolam If You Can't Fill Your Prescription.

The Bottom Line

Midazolam is not always easy to find at retail pharmacies in 2026, but supply gaps are usually solvable with some legwork. The key is knowing why shortages happen — sterile injectable manufacturing complexity, demand spikes, and specialty stocking patterns — and acting quickly. Use medfinder to locate pharmacies that have it in stock, and keep your prescriber in the loop so they can suggest alternatives if needed.